A second target of benzamide riboside: dihydrofolate reductase.
Roussel B, Johnson-Farley N, Kerrigan JE, Scotto KW, Banerjee D, Felczak K, Pankiewicz KW, Gounder M, Lin H, Abali EE, Bertino JR.
Roussel B, et al.
Cancer Biol Ther. 2012 Nov;13(13):1290-8. doi: 10.4161/cbt.21786. Epub 2012 Sep 6.
Cancer Biol Ther. 2012.
PMID: 22954684
Free PMC article.